Array BioPharma, Inc.

Biopharma company prices public offering of 8,000,000 shares of common stock

Published in Lab Business Week, January 16th, 2005

Array BioPharma, Inc., (ARRY) announced that it has priced its offering of 8,000,000 shares of common stock at a public offering price of $7.75 per share under an existing shelf registration statement.

The offering was increased by 2,000,000 shares over the proposed offering announced November 30, 2004. In connection with this offering, Array has granted UBS Investment Bank a 30-day option to purchase up to 1,200,000 additional shares of common stock to cover over-allotments, if any. The offering is expected to close on or about December 14, 2004, subject to customary conditions.

Array expects to receive net proceeds of approximately $58.0 million...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Business Week

Source: Lab Business Week (2005-01-16)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry